Javascript must be enabled to continue!
Individualized brain radiomics-based network tracks distinct subtypes and abnormal patterns in prodromal Parkinson’s disease
View through CrossRef
Abstract
Individuals in the prodromal phase of Parkinson’s disease (PD) exhibit significant heterogeneity and can be divided into distinct subtypes based on clinical symptoms, pathological mechanisms, and brain network patterns. However, little has been done regarding the valid subtyping of prodromal PD, which hinders the early diagnosis of PD. Therefore, we aimed to identify the subtypes of prodromal PD using the brain radiomics-based network and examine the unique patterns linked to the clinical presentations of each subtype. Individualized brain radiomics-based network was constructed for normal controls (NC; N = 110), prodromal PD patients (N = 262), and PD patients (N = 108). Data-driven clustering approach using the radiomics-based network was carried out to cluster prodromal PD patients into higher-/lower-risk subtypes. Then, the dissociated patterns of clinical manifestations, anatomical structure alterations, and gene expression between these two subtypes were evaluated. Clustering findings indicated that one prodromal PD subtype closely resembled the pattern of NCs (N-P; N = 159), while the other was similar to the pattern of PD (P-P; N = 103). Significant differences were observed between the subtypes in terms of multiple clinical measurements, neuroimaging for morphological changes, and gene enrichment for synaptic transmission. Identification of prodromal PD subtypes based on brain connectomes and a full understanding of heterogeneity at this phase could inform early and accurate PD diagnosis and effective neuroprotective interventions.
Title: Individualized brain radiomics-based network tracks distinct subtypes and abnormal patterns in prodromal Parkinson’s disease
Description:
Abstract
Individuals in the prodromal phase of Parkinson’s disease (PD) exhibit significant heterogeneity and can be divided into distinct subtypes based on clinical symptoms, pathological mechanisms, and brain network patterns.
However, little has been done regarding the valid subtyping of prodromal PD, which hinders the early diagnosis of PD.
Therefore, we aimed to identify the subtypes of prodromal PD using the brain radiomics-based network and examine the unique patterns linked to the clinical presentations of each subtype.
Individualized brain radiomics-based network was constructed for normal controls (NC; N = 110), prodromal PD patients (N = 262), and PD patients (N = 108).
Data-driven clustering approach using the radiomics-based network was carried out to cluster prodromal PD patients into higher-/lower-risk subtypes.
Then, the dissociated patterns of clinical manifestations, anatomical structure alterations, and gene expression between these two subtypes were evaluated.
Clustering findings indicated that one prodromal PD subtype closely resembled the pattern of NCs (N-P; N = 159), while the other was similar to the pattern of PD (P-P; N = 103).
Significant differences were observed between the subtypes in terms of multiple clinical measurements, neuroimaging for morphological changes, and gene enrichment for synaptic transmission.
Identification of prodromal PD subtypes based on brain connectomes and a full understanding of heterogeneity at this phase could inform early and accurate PD diagnosis and effective neuroprotective interventions.
Related Results
Brain Organoids, the Path Forward?
Brain Organoids, the Path Forward?
Photo by Maxim Berg on Unsplash
INTRODUCTION
The brain is one of the most foundational parts of being human, and we are still learning about what makes humans unique. Advancements ...
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Background and objective: Symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This makes t...
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Background and objective: The symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This mak...
Application of Radiomics in Predicting the Prognosis of Medulloblastoma in Children
Application of Radiomics in Predicting the Prognosis of Medulloblastoma in Children
Background and Purpose: Medulloblastoma (MB) represents the predominant intracranial neoplasm observed in pediatric populations, characterized by a five-year survival rate ranging ...
[RETRACTED] Gro-X Brain Reviews - Is Gro-X Brain A Scam? v1
[RETRACTED] Gro-X Brain Reviews - Is Gro-X Brain A Scam? v1
[RETRACTED]➢Item Name - Gro-X Brain➢ Creation - Natural Organic Compound➢ Incidental Effects - NA➢ Accessibility - Online➢ Rating - ⭐⭐⭐⭐⭐➢ Click Here To Visit - Official Website - ...
Data from Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma
Data from Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma
<div>Abstract<p><b>Purpose:</b> To identify MRI-based radiomics as prognostic factors in patients with advanced nasopharyngeal carcinoma (NPC).</p><...
Data from Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma
Data from Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma
<div>Abstract<p><b>Purpose:</b> To identify MRI-based radiomics as prognostic factors in patients with advanced nasopharyngeal carcinoma (NPC).</p><...

